With COVID-19 vaccinations beginning this week in the US, the country is entering a new stage of the pandemic that could ultimately end in widespread suppression of the virus. The implications of this ...
WICHITA, Kan. (KSNW) — As respiratory illnesses continue to surge across the state of Kansas, Wichita State University’s Molecular Diagnostic Lab has announced they are extending free testing through ...
The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its "Molecular Testing for Cancer during ...
cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
Gastrointestinal (GI) infections present a formidable challenge to healthcare systems. As we navigate this landscape, we recognize that there are numerous benefits when moving from conventional to ...
IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
THE COLONY, Texas (CBSDFW.COM) - There's a lab in North Texas where dedicated employees are working 70 hour weeks to speed up the results of COVID-19 testing. Dallas County and others depend on the ...
Global Molecular Infectious Disease Testing Market OverviewThe global Molecular Infectious Disease Testing Market encompasses ...
As the science and technology behind genomic sequencing progresses, high-throughput molecular testing has increasingly become a crucial tool in identifying diseases in their earliest stages. Despite ...
Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "North America Molecular Diagnostics Market, till 2035: Distribution by Test Type, Type of Offering, Type of Sample, Type of Technology, Therapeutic Area, ...
Hosted on MSN
Insight Molecular Diagnostics outlines $1B transplant testing market expansion as company nears FDA submission
Earnings Call Insights: Insight Molecular Diagnostics Inc. (IMDX) Q3 2025 CEO Joshua Riggs highlighted that Insight Molecular Diagnostics is nearing a transformative milestone, stating, "In 2026, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results